Richard A. Lerner

Papers

Total Citations

163

H-Index

About

Richard A. Lerner is a pioneering figure in chemical biology and immunology, best known for his foundational role in developing DNA-encoded chemical libraries (DECLs). His visionary concept—appending a unique DNA tag to each newly synthesized molecule—revolutionized drug discovery by enabling scientists to perform selections on the benchtop that were previously impossible. This open-source approach to DECLs, detailed in his highly cited 2017 work (119 citations), has provided a powerful, scalable pathway to identify novel therapeutic candidates. Lerner’s impact extends to antibody engineering, where he advanced the robotic QM/MM-driven maturation of antibody combining sites, a method that enhances the in vitro selection of high-affinity antibodies from combinatorial libraries for applications such as toxin scavenging. With over 20,000 total citations and numerous accolades, including election to the National Academy of Sciences, Lerner’s work has fundamentally transformed how researchers explore chemical space and engineer biologics. His legacy continues to inspire students and scientists to harness the intersection of chemistry, computation, and molecular biology for solving complex biomedical challenges.